+

WO1998039358B1 - Lipides cationiques oligomeres - Google Patents

Lipides cationiques oligomeres

Info

Publication number
WO1998039358B1
WO1998039358B1 PCT/US1998/004344 US9804344W WO9839358B1 WO 1998039358 B1 WO1998039358 B1 WO 1998039358B1 US 9804344 W US9804344 W US 9804344W WO 9839358 B1 WO9839358 B1 WO 9839358B1
Authority
WO
WIPO (PCT)
Prior art keywords
cationic lipids
oligomeric cationic
oligomeric
present
compositions
Prior art date
Application number
PCT/US1998/004344
Other languages
English (en)
Other versions
WO1998039358A1 (fr
WO1998039358A9 (fr
Filing date
Publication date
Priority claimed from US08/812,775 external-priority patent/US5877220A/en
Application filed filed Critical
Priority to AU66879/98A priority Critical patent/AU6687998A/en
Publication of WO1998039358A1 publication Critical patent/WO1998039358A1/fr
Publication of WO1998039358B1 publication Critical patent/WO1998039358B1/fr
Publication of WO1998039358A9 publication Critical patent/WO1998039358A9/fr

Links

Abstract

La présente invention concerne de nouveaux lipides cationiques oligomères. La présente invention concerne également des compositions de ces nouveaux lipides cationiques avec des macromolécules anioniques, des méthodes d'interférence avec une expression de protéines dans une cellule faisant appel à ces compositions, ainsi qu'une trousse destinée à leur préparation.
PCT/US1998/004344 1997-03-06 1998-03-05 Lipides cationiques oligomeres WO1998039358A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU66879/98A AU6687998A (en) 1997-03-06 1998-03-05 Oligomeric cationic lipids

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/812,775 1997-03-06
US08/812,775 US5877220A (en) 1997-03-06 1997-03-06 Amide-based oligomeric cationic lipids

Publications (3)

Publication Number Publication Date
WO1998039358A1 WO1998039358A1 (fr) 1998-09-11
WO1998039358B1 true WO1998039358B1 (fr) 1998-11-26
WO1998039358A9 WO1998039358A9 (fr) 1999-02-25

Family

ID=25210592

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/004344 WO1998039358A1 (fr) 1997-03-06 1998-03-05 Lipides cationiques oligomeres

Country Status (3)

Country Link
US (1) US5877220A (fr)
AU (1) AU6687998A (fr)
WO (1) WO1998039358A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003507430A (ja) * 1999-08-25 2003-02-25 ジーエムピー カンパニーズ,インコーポレーテッド 哺乳動物中で酸素運搬を向上する薬剤
CN101041079A (zh) * 1999-12-30 2007-09-26 诺瓦提斯公司 用于基因治疗的新的胶体合成载体
US6686461B1 (en) * 2000-03-22 2004-02-03 Solulink Bioscience, Inc. Triphosphate oligonucleotide modification reagents and uses thereof
CA2391316A1 (fr) * 2000-03-22 2001-09-27 Solulink, Incorporated Agents de reticulation bifonctionnels a base d'hydrazine et de carbonyle
US7102024B1 (en) 2000-08-01 2006-09-05 Schwartz David A Functional biopolymer modification reagents and uses thereof
AU2002348163A1 (en) * 2001-11-02 2003-05-19 Intradigm Corporation Therapeutic methods for nucleic acid delivery vehicles
WO2004002453A1 (fr) 2002-06-28 2004-01-08 Protiva Biotherapeutics Ltd. Appareil liposomal et procedes de fabrication
KR101164256B1 (ko) 2003-09-15 2012-07-10 프로티바 바이오쎄라퓨틱스, 인코포레이티드 폴리에틸렌글리콜 개질된 지질 화합물 및 그의 용도
US7158353B2 (en) * 2003-11-06 2007-01-02 Seagate Technology Llc Magnetoresistive sensor having specular sidewall layers
EA011239B1 (ru) * 2003-12-17 2009-02-27 Элан Фарма Интернэшнл Лимитед КОНЪЮГАТЫ Aβ ИММУНОГЕННЫХ ПЕПТИДНЫХ НОСИТЕЛЕЙ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
SI1701968T1 (sl) * 2003-12-17 2015-08-31 Wyeth Llc Imunogeni konjugati peptidnih nosilcev in postopek izdelave istih
WO2005121348A1 (fr) * 2004-06-07 2005-12-22 Protiva Biotherapeutics, Inc. Arn interferant encapsule dans des lipides
EP1828219A4 (fr) * 2004-11-17 2008-07-23 Protiva Biotherapeutics Inc Silence arnsi de l'apolipoproteine b
EP1948674A4 (fr) 2005-11-02 2009-02-04 Protiva Biotherapeutics Inc Molecules d'arnsi modifiees et utilisations de celles-ci
CA2710713C (fr) * 2007-12-27 2017-09-19 Protiva Biotherapeutics, Inc. Silencage de l'expression de la polo-like kinase a l'aide d'un arn interferent
WO2009086558A1 (fr) * 2008-01-02 2009-07-09 Tekmira Pharmaceuticals Corporation Compositions et procédés améliorés pour la délivrance d'acides nucléiques
PT2279254T (pt) 2008-04-15 2017-09-04 Protiva Biotherapeutics Inc Novas formulações lipídicas para entrega de ácido nucleico
CA2740000C (fr) 2008-10-09 2017-12-12 Tekmira Pharmaceuticals Corporation Lipides amines ameliores et procedes d'administration d'acides nucleiques
WO2010083615A1 (fr) 2009-01-26 2010-07-29 Protiva Biotherapeutics, Inc. Compositions et procédés d'inactivation de l'expression de l'apolipoprotéine c-iii
WO2011000107A1 (fr) 2009-07-01 2011-01-06 Protiva Biotherapeutics, Inc. Formulations lipidiques inédites permettant l'administration d'agents thérapeutiques en direction de tumeurs solides
US8569256B2 (en) 2009-07-01 2013-10-29 Protiva Biotherapeutics, Inc. Cationic lipids and methods for the delivery of therapeutic agents
US9018187B2 (en) 2009-07-01 2015-04-28 Protiva Biotherapeutics, Inc. Cationic lipids and methods for the delivery of therapeutic agents
WO2011011447A1 (fr) 2009-07-20 2011-01-27 Protiva Biotherapeutics, Inc. Compositions et méthodes pour rendre silencieuse l’expression du gène du virus ebola
WO2011084721A2 (fr) * 2009-12-21 2011-07-14 Agave Pharma Inc Molécule cationique et procédé d'utilisation
US8455455B1 (en) 2010-03-31 2013-06-04 Protiva Biotherapeutics, Inc. Compositions and methods for silencing genes involved in hemorrhagic fever
US9006417B2 (en) 2010-06-30 2015-04-14 Protiva Biotherapeutics, Inc. Non-liposomal systems for nucleic acid delivery
US8466122B2 (en) 2010-09-17 2013-06-18 Protiva Biotherapeutics, Inc. Trialkyl cationic lipids and methods of use thereof
US9035039B2 (en) 2011-12-22 2015-05-19 Protiva Biotherapeutics, Inc. Compositions and methods for silencing SMAD4
EP4295895A3 (fr) 2017-05-11 2024-03-27 Tc1 Llc Interconnexion thermique pour pompe à sang implantable
US11591544B2 (en) 2020-11-25 2023-02-28 Akagera Medicines, Inc. Ionizable cationic lipids
US12064479B2 (en) 2022-05-25 2024-08-20 Akagera Medicines, Inc. Lipid nanoparticles for delivery of nucleic acids and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897355A (en) * 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5693622A (en) * 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
FR2645866B1 (fr) * 1989-04-17 1991-07-05 Centre Nat Rech Scient Nouvelles lipopolyamines, leur preparation et leur emploi
DE69126530T2 (de) * 1990-07-27 1998-02-05 Isis Pharmaceutical, Inc., Carlsbad, Calif. Nuklease resistente, pyrimidin modifizierte oligonukleotide, die die gen-expression detektieren und modulieren
EP0558634A4 (en) * 1990-11-23 1995-06-28 Gilead Sciences Inc Triplex-forming oligomers containing modified bases
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
US5777153A (en) * 1994-07-08 1998-07-07 Gilead Sciences, Inc. Cationic lipids
AU701106B2 (en) * 1995-06-07 1999-01-21 Promega Biosciences, Inc. Novel carbamate-based cationic lipids
AU707947B2 (en) * 1995-07-21 1999-07-22 Promega Biosciences, Inc. Novel amide-based cationic lipids

Similar Documents

Publication Publication Date Title
WO1998039358B1 (fr) Lipides cationiques oligomeres
WO1998039359B1 (fr) Lipides cationiques dimeres sur une base de cystine
RU94042922A (ru) Новые соединения, способы их получения, фармацевтическая композиция
IL126666A0 (en) Process for the preparation of polyalkenamines
WO1999030548B1 (fr) Procede de preparation de la citaloprame
CA2103838A1 (fr) 7-(substituant)-8-(substituant)-9-[(glycyle substitue)amido]-6-demethyl-6-desoxytetracyclines
WO2003006570B1 (fr) Nouveaux mesogenes et procedes de synthese et d'utilisation de ces derniers
WO2002072588A3 (fr) Molecules detectrices de fluorescence par transfert d'electrons photo-induits
KR960034204A (ko) 항-천식 작용을 지닌 피리도[3,2-e]피라지논 및 이의 제조방법
CA2266189A1 (fr) Melanges de colorants azoiques disperses
CA2323150A1 (fr) Nouvelles porphyrines et leur utilisation
KR20010012974A (ko) 액상 벤즈-이소-퀴놀린 유도체
AU3394793A (en) Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
CA2053820A1 (fr) Methode d'inhibition du metabolisme du cholesterol
DE69808435D1 (de) Wässerige dispersionen von einem hydrophoben leimungsmittel
CA2299429A1 (fr) Nouvelles lipopolyamines, leurs methodes de preparation, et utilisations connexes
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
AU4884685A (en) New adamantanamine derivatives, processes for their preparation and drugs in which they are present
AU2309695A (en) Process for preparing 7-trialkylsilyl baccatin iii
AU649499B2 (en) Fluorine compounds
TR199800403A2 (xx) a-Bromo-laktam t�revlerinin haz�rlanmas� i�in y�ntem.
KR910000775A (ko) 무라밀 디펩티드 유도체
WO1999054322B1 (fr) Semi-synthese de baccatine iii
PT98976A (pt) Processo para a preparacao de heteroarilmetilbenzenos
IL138638A0 (en) Processes for preparing intermediates
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载